Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited ...
Kian Sadeghi, the 25-year-old founder and CEO at Nucleus Genomics, tells "CBS Mornings" that parents have every right to select the qualities and traits they desire in their child.
When DNA breaks, cells must repair it accurately to prevent harmful mutations. Researchers have discovered that during a key ...
Researchers at North Carolina State University have developed a new suite of statistical methods that dramatically improves ...
Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...
Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have published a study demonstrating the use of an advanced ...
News-Medical.Net on MSN
AI model ranks genetic variants from severe to mild disease mutations
EVE combines evolutionary insights with human population data to identify damaging genetic mutations, improving variant ...
Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...
Study Finds on MSN
Can Scientists Map Which Neurons Are Active Right Now? This Study Did
Scientists mapped brain activity across the day and found the same neurons create completely different networks depending on ...
IBM will reportedly pay $11B for the data streaming company. Lilly, Pfizer, J&J in China’s private insurance catalog. White ...
Researchers tracked brain activity across 24 hours, showing how shifting neural control centers drive fatigue and how sleep ...
CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback